首页> 美国卫生研究院文献>Heart Lung and Vessels >Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses

【2h】

Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses

机译：新型口服抗凝剂对心房颤动的比较效果：成对和华法林控制网络荟萃分析的证据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

IntroductionNovel oral anticoagulants have been tested against warfarin for atrial fibrillation, yet no direct comparison is available. We thus aimed to perform pair-wise (direct) and warfarin-adjusted network (i.e. indirect) meta-analyses of novel oral anticoagulants for atrial fibrillation.

机译：简介新型口服抗凝药已针对华法林进行房颤测试，但尚无直接比较。因此，我们旨在进行新型口服抗凝剂对房颤进行成对（直接）和华法林调整网络（即间接）荟萃分析。

著录项

期刊名称 Heart Lung and Vessels
作者
G Biondi-Zoccai; V Malavasi; F DAscenzo; A Abbate; P Agostoni; M Lotrionte; D Castagno; B Van Tassell; E Casali; M Marietta; M G Modena; K A Ellenbogen; G Frati;
展开▼
作者单位

展开▼
年(卷),期 2013(5),1
年度 2013
页码 40–54
总页数 15
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
apixaban atrial fibrillation dabigatran meta-analysis rivaroxaban systematic review warfarin;

机译：阿哌沙班;房颤;达比加群;荟萃分析;利伐沙班;系统评价;华法林;

相似文献

外文文献
中文文献
专利

1. Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses [J] . G. Biondi-Zoccai#x0002a, 1, V. Malavasi2, HSR Proceedings in Intensive Care & Cardiovascular Anesthesia . 2013,第1期

机译：新型口服抗凝剂对心房颤动的比较有效性：成对和华法林控制网络荟萃分析的证据
2. Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies [J] . Anneka Mitchell, Margaret C. Watson, Tomas Welsh, Journal of Clinical Medicine . 2019,第4期

机译：直接口服抗凝剂和维生素K拮抗剂对75岁及以上心房颤动患者的有效性和安全性：观察性研究的系统评价和荟萃分析
3. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses [J] . Almutairi Abdulaali R., Zhou Lili, Gellad Walid F., Clinical therapeutics . 2017,第7期

机译：非维生素K拮抗剂口腔抗凝剂对心房颤动和静脉血栓栓塞的有效性和安全性：系统评价和荟萃分析
4. What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation? [C] . R. CAZZIN, P. SERRA, C. FUSILLI International Workshop on Cardiac Arrhythmias . 2004

机译：在心房颤动的门诊患者中启动口服抗凝血治疗的最佳实用方案是什么？
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies [O] . Anneka Mitchell, Margaret C. Watson, Tomas Welsh, 2019

机译：口服抗凝剂与维生素K拮抗剂对75岁及以上心房颤动的有效性和安全性：观察性研究的系统评价和荟萃分析
7. PICKING THE BEST NOVEL ORAL ANTICOAGULANT FOR ATRIAL FIBRILLATION: EVIDENCE FROM A WARFARIN-CONTROLLED NETWORK META-ANALYSIS [O] . Roversi Sara, Malavasi Vincenzo, Dapos, 2012

机译：为房颤选择最佳的新型口服抗凝剂：Warfarin控制的网络元分析的证据

Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅